Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02649673
Title LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications

lung small cell carcinoma

ovarian cancer

fallopian tube cancer

peritoneum cancer

Therapies

LCL161 + Topotecan

Age Groups: adult
Covered Countries USA


No variant requirements are available.